Retter Andrew bought VNRX
May 23, 2024 · Form 4 insider transaction
Retter Andrew bought 100,000 shares of VolitionRx Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderRetter Andrew
RoleOfficer
CompanyVolitionRx Limited (VNRX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 23, 2024
Filing dateMay 24, 2024
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
In connection with his employment as Chief Medical Officer of Volition Diagnostics UK Limited, Dr. Retter received restricted stock units ("RSUs") subject to a 3-year vesting schedule, vesting as to 33,334 units, 33,333 units, and 33,333 units on each of May 23, 2025, May 23, 2026 and May 23, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.